1. Home
  2. AVTR vs PTGX Comparison

AVTR vs PTGX Comparison

Compare AVTR & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avantor Inc.

AVTR

Avantor Inc.

HOLD

Current Price

$17.19

Market Cap

11.0B

Sector

Industrials

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$139.17

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVTR
PTGX
Founded
1904
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.0B
9.3B
IPO Year
2019
2016

Fundamental Metrics

Financial Performance
Metric
AVTR
PTGX
Price
$17.19
$139.17
Analyst Decision
Hold
Strong Buy
Analyst Count
16
14
Target Price
$15.46
★ $178.21
AVG Volume (30 Days)
★ 8.0M
722.9K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
0.06
★ 2.35
Revenue
★ $6,552,200,000.00
N/A
Revenue This Year
$0.64
$1,077.07
Revenue Next Year
$2.27
N/A
P/E Ratio
$284.58
★ $59.42
Revenue Growth
N/A
★ N/A
52 Week Low
$7.27
$74.03
52 Week High
$17.45
$160.81

Technical Indicators

Market Signals
Indicator
AVTR
PTGX
Relative Strength Index (RSI) 73.74 48.84
Support Level $13.20 $135.10
Resistance Level N/A $142.20
Average True Range (ATR) 0.48 6.12
MACD 0.14 0.22
Stochastic Oscillator 89.36 49.12

Price Performance

Historical Comparison
AVTR
PTGX

About AVTR Avantor Inc.

Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: